It has been more than three decades since the first monoclonal antibody was approved by
the United States Food and Drug Administration (US FDA) in 1986, and during this time, …

Combinatorial phage library is a powerful research tool for high-throughput screening of
protein interactions. Of all available molecular display techniques, phage display has proven to …

The antibody response to the envelope (E) glycoprotein of dengue virus (DENV) is known to
play a critical role in both protection from and enhancement of disease, especially after …

The novel coronavirus disease (COVID-19) pandemic remains a global public health crisis,
presenting a broad range of challenges. To help address some of the main problems, the …

The B.1.1.7 variant of SARS-CoV-2 first detected in the UK harbors amino-acid substitutions
and deletions in the spike protein that potentially enhance host angiotensin conversion …

Studies of the pathogenesis of dengue hemorrhagic fever (DHF), a potentially life-threatening
disease, have revealed the importance of initial high levels of virus replication. However, …

Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel
treatment strategies derived from increased knowledge of molecular oncology are constantly …

The first description of cancer is found in an Egyptian papyrus and dates back to approximately
1600 BC. It was regarded as an incurable disease until the nineteenth century, when …

The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public health crisis
that demands the timely creation of new therapeutics and viral detection. Owing to their high …

Antiangiogenesis therapies for the treatment of cancers hold the promise of high efficacy and
low toxicity. In vivo phage display was used to identify peptides specifically targeting tumor …